Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1517819 | 0.83 | TSHR (0.35) | MAPTTSHRFAAHTP53CHRM2 | |
| SCHEMBL28355468 | 0.83 | MAPT (0.41) | MAPTTSHRFAAH | |
| SCHEMBL1216964 | 0.82 | MAPT (0.43) | MAPTTSHRFAAHCHRM2CHRM4 | |
| SCHEMBL779893 | 0.82 | MAPT (0.43) | MAPTTSHRFAAHCHRM2CHRM4 | |
| SCHEMBL2980611 | 0.82 | MAPT (0.43) | MAPTTSHRFAAHCHRM2CHRM4 | |
| SCHEMBL4530794 | 0.81 | FAAH (0.44) | MAPTTSHRFAAHCHRM1ALDH1A1 | |
| SCHEMBL24414625 | 0.80 | TDP1 (0.36) | MAPTTSHRFAAHTP53CHRM2 | |
| SCHEMBL24414483 | 0.80 | TDP1 (0.36) | MAPTTSHRFAAHTP53CHRM2 | |
| SCHEMBL24414509 | 0.80 | TDP1 (0.36) | MAPTTSHRFAAHTP53CHRM2 | |
| SCHEMBL4439936 | 0.80 | MAPT (0.42) | MAPTTSHRFAAHCHRM2CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 265 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119529249-A | Method for producing polylactic acid-glycolic acid copolymer, and polylactic acid-glycolic acid copolymer produced by said method | 中国石油大学(华东) | 2025-02-28 | — | — | CN | claimed |
| CN-117126383-A | Method for preparing high molecular weight polylactic acid | 中国石油大学(华东) | 2023-11-28 | — | — | CN | claimed |
| WO-2023222042-A1 | MANUFACTURING METHOD FOR HIGH-MOLECULAR-WEIGHT POLYLACTIC ACID | 中国石油大学(华东) | 2023-11-23 | — | — | WO | claimed |
| US-20220184165-A1 | Novel Compounds and Pharmaceutical Preparations | DICOT AB (SE) | 2022-06-16 | — | — | US | claimed |
| US-20190142000-A1 | High Concentration Low VOC Liquid Gibberellin | STOLLER ENTERPRISES, INC. (US) | 2019-05-16 | — | — | US | claimed |
| US-10194658-B2 | High concentration low VOC liquid gibberellin | STOLLER ENTERPRISES, INC. (US) | 2019-02-05 | — | — | US | claimed |
| WO-2018099836-A1 | PLANARIZING COATING-FORMING COMPOSITION AND METHODS FOR MANUFACTURING PLANARIZING COATING AND DEVICE USING THE SAME | AZ ELECTRONIC MATERIALS (LUXEMBOURG) S.A.R.L. (LU) | 2018-06-07 | — | — | WO | claimed |
| WO-2018099848-A1 | PLANARISING COATING-FORMING COMPOSITION AND METHODS FOR MANUFACTURING PLANARIZING COATING AND DEVICE USING THE SAME | AZ ELECTRONIC MATERIALS (LUXEMBOURG) S.A.R.L. (LU) | 2018-06-07 | — | — | WO | claimed |
| EP-2162145-B1 | NOVEL COMPOUNDS AND PHARMACEUTICAL PREPARATIONS FROM NEOBEGUEA SPEC | DICOTYLEDON AB (SE) | 2016-05-04 | — | — | EP | claimed |
| US-7863025-B2 | Synthesis of fatty alcohol esters of alpha-hydroxy carboxylic acids and their use as percutaneous absorption enhancers | CHEMIC LABORATORIES, INC. (US) | 2011-01-04 | — | — | US | claimed |
| US-20100247593-A1 | NOVEL COMPOUNDS AND PHARMACEUTICAL PREPARATIONS | DICOTYLEDON AB (SE) | 2010-09-30 | — | — | US | claimed |
| EP-2162145-A2 | NOVEL COMPOUNDS AND PHARMACEUTICAL PREPARATIONS FROM NEOBEGUEA SPEC | Dicotyledon AB (SE) | 2010-03-17 | — | — | EP | claimed |
| WO-2008145996-A2 | NOVEL COMPOUNDS AND PHARMACEUTICAL PREPARATIONS | DICOTYLEDON AB (SE) | 2008-12-04 | — | — | WO | claimed |
| US-7081248-B2 | Concentrated water-dispersible vitamin compositions | ADISSEO FRANCE S.A.S. (FR) | 2006-07-25 | — | — | US | claimed |
| US-20250263629-A1 | MUSKY ODORANT | FIRMENICH SA (CH) | 2025-08-21 | — | — | US | disclosed |
| CN-119529249-A | Method for producing polylactic acid-glycolic acid copolymer, and polylactic acid-glycolic acid copolymer produced by said method | 中国石油大学(华东) | 2025-02-28 | — | — | CN | disclosed |
| US-20240410055-A1 | METHOD AND FORMULATION FOR PREPARING OPTICAL METAL OXIDE LAYERS | MERCK PATENT GMBH (DE) | 2024-12-12 | — | — | US | disclosed |
| EP-0459455-B1 | Process for producing optically active alpha-hydroxyesters | CHISSO CORP (JP) | 1996-09-04 | — | — | EP | disclosed |
| US-5248610-A | Transesterification | CHISSO CORPORATION (JP) | 1993-09-28 | — | — | US | disclosed |
| EP-0459455-A2 | Process for producing optically active alpha-hydroxyesters | CHISSO CORPORATION (JP) | 1991-12-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220184165-A1 | Novel Compounds and Pharmaceutical Preparations | PDE8B, PDE3B, PDE4D | MAPT 2858/4885TSHR 4076/4885FAAH 2257/4885 |
| US-20250263629-A1 | MUSKY ODORANT | TRPA1, MSMO1, MSH2 | MAPT 1991/4885TSHR 4605/4885FAAH 31/4885 |
| US-20100247593-A1 | NOVEL COMPOUNDS AND PHARMACEUTICAL PREPARATIONS | PDE4B, ACHE, PDE5A | MAPT 1188/4885TSHR 2169/4885FAAH 2061/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.